Trial Profile
Efavirenz Pharmacokinetics and Pharmacogenomics in Older HIV-infected Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Sep 2023
Price :
$35
*
At a glance
- Drugs Efavirenz (Primary)
- Indications HIV infections
- Focus Pharmacogenomic; Pharmacokinetics
- 03 Dec 2014 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 02 Jan 2014 Status changed from not yet recruiting to recruiting, as per ClinicalTrials.gov record.
- 18 Jul 2013 New trial record